COV 0.00% 34.5¢ cleo diagnostics ltd

Hello. The chairman (Adrien Wing; recalling speaking to him...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,533 Posts.
    lightbulb Created with Sketch. 213
    Hello. The chairman (Adrien Wing; recalling speaking to him years ago with NAE) appears to be founding & seed investor.

    This announcement https://announcements.asx.com.au/asxpdf/20230821/pdf/05svr7c46kdqr0.pdf says:

    * Adrien Wing 14,250,000 shares; 6,500,000 x 2 shares bought for $6,500 x 2 ($0.001 cents each) and 1,250,000 shares for $250,000 or 20 cents each.

    * Richard Vom appears to be another founding seed investor, with 8,500,000 shares costing $8,500 and also 625,000 for $125,000 or 20 cents each.

    * Hudson Institute 7,500,000 shares non-cash for Licensing Agreement.

    The Prospectus (page 100) says about the Licensing Agreement: https://announcements.asx.com.au/asxpdf/20230818/pdf/05ssh95z0p6v30.pdf

    * $500,000 (already paid)

    * 7,500,000 shares (already issued)

    * upon the Company achieving regulatory approval for its first product in any of the US, Australia, Europe or Japan, pay Hudson $1,500,000 (excluding
    GST).

    * a royalty calculated as the sum of 3% of sales or supplies of any product; plus (subject to certain conditions) either 20%, 15% or10% of receipts from the right to use the Licenced Technology



    Last edited by GKeden: 05/06/24
 
watchlist Created with Sketch. Add COV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.